A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

NCT01560104 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small -Cell Lung Cancer

Interventions

DRUG: Veliparib
DRUG: Carboplatin
DRUG: paclitaxel
DRUG: placebo

Sponsor

AbbVie (prior sponsor, Abbott)